_id
691300dfccc777a4e85d78f0
Ticker
IKT
Name
Inhibikase Therapeutics Inc
Exchange
NASDAQ
Address
3350 Riverwood Parkway SE, Atlanta, GA, United States, 30339
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.inhibikase.com
Description
Inhibikase Therapeutics, Inc. operates as a clinical-stage pharmaceutical company that develops therapeutics for Parkinson's disease and related disorders. Its lead product candidate is IkT-148009, a non-receptor Abelson tyrosine kinase inhibitor, which is in Phase 2a clinical trials to the treatment of Parkinson's disease and gastrointestinal tract. The company is also developing IkT-001Pro, a prodrug of the anticancer agent imatinib mesylate to treat stable phase chronic myelogenous leukemia. Inhibikase Therapeutics, Inc. has research and development collaborations with Johns Hopkins University, Arizona State University, and Michigan State University; and a collaborative research and development agreement with Sphaera Pharma Pte. Ltd. The company was founded in 2008 and is based in Atlanta, Georgia.
Last Close
1.525
Volume
253995
Current Price
1.535
Change
0.6557377049180334
Last Updated
2025-12-01T09:16:33.097Z
Image
-
Ipo Date
2020-12-23T00:00:00.000Z
Market Cap
119226616
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.8541428571428572
Sentiment Sources
7
Rating
4.5
Target Price
8
Strong Buy
1
Buy
1
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
23688
Gross Profit
-23688
Operating Expenses
13237512
Operating Income
-13261200
Interest Expense
-
Pretax Income
-11930280
Net Income
-11930280
Eps
-0.13248363235342275
Dividends Per Share
-
Shares Outstanding
74516635
Income Tax Expense
-
EBITDA
-11906592
Operating Margin
-
Total Other Income Expense Net
1330920
Cash
38269706
Short Term Investments
39052511
Receivables
-
Inventories
-
Total Current Assets
78536628
Property Plant Equipment
0
Total Assets
79594541
Payables
620528
Short Term Debt
-
Long Term Debt
-
Total Liabilities
6696243
Equity
72898298
Depreciation
23688
Change In Working Capital
-2148013
Cash From Operations
-10592730
Capital Expenditures
452023
Cash From Investing
-28746103
Cash From Financing
-134130
Net Change In Cash
-39472963
PE
-
PB
1.8961792983836192
ROE
-16.365649579363293
ROA
-14.988816883811165
FCF
-11044753
Fcf Percent
-
Piotroski FScore
1
Health Score
43
Deep Value Investing Score
4
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2
Net Net Investing Score
3
Quality Investing Score
2.5
Value Investing Score
6
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
23688
Quarters > 0 > income Statement > gross Profit
-23688
Quarters > 0 > income Statement > operating Expenses
13237512
Quarters > 0 > income Statement > operating Income
-13261200
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-11930280
Quarters > 0 > income Statement > net Income
-11930280
Quarters > 0 > income Statement > eps
-0.13248363235342275
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
90050973
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-11906592
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
1330920
Quarters > 0 > balance Sheet > cash
38269706
Quarters > 0 > balance Sheet > short Term Investments
39052511
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
78536628
Quarters > 0 > balance Sheet > property Plant Equipment
0
Quarters > 0 > balance Sheet > total Assets
79594541
Quarters > 0 > balance Sheet > payables
620528
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
6696243
Quarters > 0 > balance Sheet > equity
72898298
Quarters > 0 > cash Flow > net Income
-11930280
Quarters > 0 > cash Flow > depreciation
23688
Quarters > 0 > cash Flow > change In Working Capital
-2148013
Quarters > 0 > cash Flow > cash From Operations
-10592730
Quarters > 0 > cash Flow > capital Expenditures
452023
Quarters > 0 > cash Flow > cash From Investing
-28746103
Quarters > 0 > cash Flow > cash From Financing
-134130
Quarters > 0 > cash Flow > net Change In Cash
-39472963
Quarters > 0 > ratios > PE
-0.13248363235342275
Quarters > 0 > ratios > PB
1.8961792983836192
Quarters > 0 > ratios > ROE
-16.365649579363293
Quarters > 0 > ratios > ROA
-14.988816883811165
Quarters > 0 > ratios > FCF
-11044753
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
43
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
24157
Quarters > 1 > income Statement > gross Profit
-24157
Quarters > 1 > income Statement > operating Expenses
10832278
Quarters > 1 > income Statement > operating Income
-10832278
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-9915523
Quarters > 1 > income Statement > net Income
-9915523
Quarters > 1 > income Statement > eps
-0.11016069670326924
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
90009625
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-11166540
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
916755
Quarters > 1 > balance Sheet > cash
77742669
Quarters > 1 > balance Sheet > short Term Investments
9923100
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
88794625
Quarters > 1 > balance Sheet > property Plant Equipment
58605
Quarters > 1 > balance Sheet > total Assets
88853230
Quarters > 1 > balance Sheet > payables
2703554
Quarters > 1 > balance Sheet > short Term Debt
37944
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
8799545
Quarters > 1 > balance Sheet > equity
80053685
Quarters > 1 > cash Flow > net Income
-9915523
Quarters > 1 > cash Flow > depreciation
24158
Quarters > 1 > cash Flow > change In Working Capital
466812
Quarters > 1 > cash Flow > cash From Operations
-5574231
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
9843738
Quarters > 1 > cash Flow > cash From Financing
31771
Quarters > 1 > cash Flow > net Change In Cash
4301278
Quarters > 1 > ratios > PE
-0.11016069670326924
Quarters > 1 > ratios > PB
1.72590149191758
Quarters > 1 > ratios > ROE
-12.386091908198853
Quarters > 1 > ratios > ROA
-11.159440123898703
Quarters > 1 > ratios > FCF
-5574231
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
43
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
12654
Quarters > 2 > income Statement > gross Profit
-12654
Quarters > 2 > income Statement > operating Expenses
14598006
Quarters > 2 > income Statement > operating Income
-14598006
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-13678735
Quarters > 2 > income Statement > net Income
-13678735
Quarters > 2 > income Statement > eps
-0.1527715790797098
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
89537171
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-15750216
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
919271
Quarters > 2 > balance Sheet > cash
73441390
Quarters > 2 > balance Sheet > short Term Investments
19738900
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
94164758
Quarters > 2 > balance Sheet > property Plant Equipment
116564
Quarters > 2 > balance Sheet > total Assets
94281322
Quarters > 2 > balance Sheet > payables
1692051
Quarters > 2 > balance Sheet > short Term Debt
74772
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
8550650
Quarters > 2 > balance Sheet > equity
85730671
Quarters > 2 > cash Flow > net Income
-13678735
Quarters > 2 > cash Flow > depreciation
12654
Quarters > 2 > cash Flow > change In Working Capital
1327925
Quarters > 2 > cash Flow > cash From Operations
-4103530
Quarters > 2 > cash Flow > capital Expenditures
13399
Quarters > 2 > cash Flow > cash From Investing
21054342
Quarters > 2 > cash Flow > cash From Financing
0
Quarters > 2 > cash Flow > net Change In Cash
16950812
Quarters > 2 > ratios > PE
-0.1527715790797098
Quarters > 2 > ratios > PB
1.6031550422018743
Quarters > 2 > ratios > ROE
-15.95547409164685
Quarters > 2 > ratios > ROA
-14.508425115209988
Quarters > 2 > ratios > FCF
-4116929
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
43
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
26274
Quarters > 3 > income Statement > cost Of Revenue
6567
Quarters > 3 > income Statement > gross Profit
-6567
Quarters > 3 > income Statement > operating Expenses
12922133
Quarters > 3 > income Statement > operating Income
-12928700
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-12132577
Quarters > 3 > income Statement > net Income
-12132577
Quarters > 3 > income Statement > eps
-0.17491566292817357
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
69362439
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-12126010
Quarters > 3 > income Statement > operating Margin
-49207.20103524397
Quarters > 3 > income Statement > total Other Income Expense Net
796123
Quarters > 3 > balance Sheet > cash
56490579
Quarters > 3 > balance Sheet > short Term Investments
41052949
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
98451309
Quarters > 3 > balance Sheet > property Plant Equipment
148537
Quarters > 3 > balance Sheet > total Assets
98599846
Quarters > 3 > balance Sheet > payables
943019
Quarters > 3 > balance Sheet > short Term Debt
110517
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
3733566
Quarters > 3 > balance Sheet > equity
94866280
Quarters > 3 > cash Flow > net Income
-12132577
Quarters > 3 > cash Flow > depreciation
6567
Quarters > 3 > cash Flow > change In Working Capital
-1128027
Quarters > 3 > cash Flow > cash From Operations
-5345575
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-38761725
Quarters > 3 > cash Flow > cash From Financing
99684459
Quarters > 3 > cash Flow > net Change In Cash
55577159
Quarters > 3 > ratios > PE
-0.17491566292817357
Quarters > 3 > ratios > PB
1.1223307571984482
Quarters > 3 > ratios > ROE
-12.789135401957367
Quarters > 3 > ratios > ROA
-12.304864046136544
Quarters > 3 > ratios > FCF
-5345575
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-203.45493643906522
Quarters > 3 > health Score
35
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
26272
Annuals > 0 > income Statement > gross Profit
-26272
Annuals > 0 > income Statement > operating Expenses
28562796
Annuals > 0 > income Statement > operating Income
-28589068
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-27519886
Annuals > 0 > income Statement > net Income
-27519886
Annuals > 0 > income Statement > eps
-0.3967548776651294
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
69362439
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-27493614
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
1069182
Annuals > 0 > balance Sheet > cash
56490579
Annuals > 0 > balance Sheet > short Term Investments
41052949
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
98451309
Annuals > 0 > balance Sheet > property Plant Equipment
148537
Annuals > 0 > balance Sheet > total Assets
98599846
Annuals > 0 > balance Sheet > payables
943019
Annuals > 0 > balance Sheet > short Term Debt
110517
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
3733566
Annuals > 0 > balance Sheet > equity
94866280
Annuals > 0 > cash Flow > net Income
-27519886
Annuals > 0 > cash Flow > depreciation
26272
Annuals > 0 > cash Flow > change In Working Capital
204930
Annuals > 0 > cash Flow > cash From Operations
-19148067
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-37004201
Annuals > 0 > cash Flow > cash From Financing
103477668
Annuals > 0 > cash Flow > net Change In Cash
47325400
Annuals > 0 > ratios > PE
-0.3967548776651294
Annuals > 0 > ratios > PB
1.111363355662307
Annuals > 0 > ratios > ROE
-29.009133698506993
Annuals > 0 > ratios > ROA
-27.9106784811814
Annuals > 0 > ratios > FCF
-19148067
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
260500
Annuals > 1 > income Statement > cost Of Revenue
13618348
Annuals > 1 > income Statement > gross Profit
-13357848
Annuals > 1 > income Statement > operating Expenses
6731944
Annuals > 1 > income Statement > operating Income
-20089792
Annuals > 1 > income Statement > interest Expense
74453
Annuals > 1 > income Statement > pretax Income
-19028883
Annuals > 1 > income Statement > net Income
-19028883
Annuals > 1 > income Statement > eps
-3.5680743418082104
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
5333096
Annuals > 1 > income Statement > income Tax Expense
-148906
Annuals > 1 > income Statement > EBITDA
-19912394
Annuals > 1 > income Statement > operating Margin
-7712.012284069098
Annuals > 1 > income Statement > total Other Income Expense Net
1060909
Annuals > 1 > balance Sheet > cash
9165179
Annuals > 1 > balance Sheet > short Term Investments
4086872
Annuals > 1 > balance Sheet > receivables
39881
Annuals > 1 > balance Sheet > inventories
1117616
Annuals > 1 > balance Sheet > total Current Assets
14211048
Annuals > 1 > balance Sheet > property Plant Equipment
295599
Annuals > 1 > balance Sheet > total Assets
14506647
Annuals > 1 > balance Sheet > payables
646767
Annuals > 1 > balance Sheet > short Term Debt
531879
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
3528725
Annuals > 1 > balance Sheet > equity
10977922
Annuals > 1 > cash Flow > net Income
-19028883
Annuals > 1 > cash Flow > depreciation
177398
Annuals > 1 > cash Flow > change In Working Capital
234758
Annuals > 1 > cash Flow > cash From Operations
-18085043
Annuals > 1 > cash Flow > capital Expenditures
14238
Annuals > 1 > cash Flow > cash From Investing
11656666
Annuals > 1 > cash Flow > cash From Financing
8405003
Annuals > 1 > cash Flow > net Change In Cash
1976626
Annuals > 1 > ratios > PE
-3.5680743418082104
Annuals > 1 > ratios > PB
0.7384189758316738
Annuals > 1 > ratios > ROE
-173.33775007692714
Annuals > 1 > ratios > ROA
-131.17354410016318
Annuals > 1 > ratios > FCF
-18099281
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-69.47900575815738
Annuals > 1 > health Score
33
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
123440
Annuals > 2 > income Statement > cost Of Revenue
6723
Annuals > 2 > income Statement > gross Profit
116717
Annuals > 2 > income Statement > operating Expenses
18128608
Annuals > 2 > income Statement > operating Income
-18128608
Annuals > 2 > income Statement > interest Expense
74453
Annuals > 2 > income Statement > pretax Income
-18054155
Annuals > 2 > income Statement > net Income
-17905249
Annuals > 2 > income Statement > eps
-4.261172064234877
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
4201954
Annuals > 2 > income Statement > income Tax Expense
-148906
Annuals > 2 > income Statement > EBITDA
-18121885
Annuals > 2 > income Statement > operating Margin
-14686.169799092675
Annuals > 2 > income Statement > total Other Income Expense Net
74453
Annuals > 2 > balance Sheet > cash
7188553
Annuals > 2 > balance Sheet > short Term Investments
15861620
Annuals > 2 > balance Sheet > receivables
39881
Annuals > 2 > balance Sheet > inventories
1117616
Annuals > 2 > balance Sheet > total Current Assets
24371122
Annuals > 2 > balance Sheet > property Plant Equipment
565175
Annuals > 2 > balance Sheet > total Assets
24936297
Annuals > 2 > balance Sheet > payables
1151173
Annuals > 2 > balance Sheet > short Term Debt
145836
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
3900896
Annuals > 2 > balance Sheet > equity
21035401
Annuals > 2 > cash Flow > net Income
-18054155
Annuals > 2 > cash Flow > depreciation
6723
Annuals > 2 > cash Flow > change In Working Capital
171182
Annuals > 2 > cash Flow > cash From Operations
-17351103
Annuals > 2 > cash Flow > capital Expenditures
243255
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
-204769
Annuals > 2 > cash Flow > net Change In Cash
-33561580
Annuals > 2 > ratios > PE
-4.261172064234877
Annuals > 2 > ratios > PB
0.30362958519307526
Annuals > 2 > ratios > ROE
-85.1195990986813
Annuals > 2 > ratios > ROA
-71.80396110938204
Annuals > 2 > ratios > FCF
-17594358
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-142.53368438107583
Annuals > 2 > health Score
33
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
3100605
Annuals > 3 > income Statement > cost Of Revenue
11359104
Annuals > 3 > income Statement > gross Profit
3100605
Annuals > 3 > income Statement > operating Expenses
14766140
Annuals > 3 > income Statement > operating Income
-14766140
Annuals > 3 > income Statement > interest Expense
19923
Annuals > 3 > income Statement > pretax Income
-14786063
Annuals > 3 > income Statement > net Income
-14805986
Annuals > 3 > income Statement > eps
-4.878629237666506
Annuals > 3 > income Statement > dividends Per Share
77652
Annuals > 3 > income Statement > shares Outstanding
3034866
Annuals > 3 > income Statement > income Tax Expense
19923
Annuals > 3 > income Statement > EBITDA
-14766140
Annuals > 3 > income Statement > operating Margin
-476.23415430214425
Annuals > 3 > income Statement > total Other Income Expense Net
-19923
Annuals > 3 > balance Sheet > cash
40750133
Annuals > 3 > balance Sheet > short Term Investments
0
Annuals > 3 > balance Sheet > receivables
110141
Annuals > 3 > balance Sheet > inventories
107000
Annuals > 3 > balance Sheet > total Current Assets
42469999
Annuals > 3 > balance Sheet > property Plant Equipment
0
Annuals > 3 > balance Sheet > total Assets
42469999
Annuals > 3 > balance Sheet > payables
1089778
Annuals > 3 > balance Sheet > short Term Debt
248911
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
4054450
Annuals > 3 > balance Sheet > equity
38415549
Annuals > 3 > cash Flow > net Income
-14786063
Annuals > 3 > cash Flow > depreciation
0
Annuals > 3 > cash Flow > change In Working Capital
-1764489
Annuals > 3 > cash Flow > cash From Operations
-14297051
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
41093671
Annuals > 3 > cash Flow > net Change In Cash
26796620
Annuals > 3 > ratios > PE
-4.878629237666506
Annuals > 3 > ratios > PB
0.12008148887837058
Annuals > 3 > ratios > ROE
-38.541648851614745
Annuals > 3 > ratios > ROA
-34.862223566334436
Annuals > 3 > ratios > FCF
-14297051
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-4.61105203661866
Annuals > 3 > health Score
33
Valuation > metrics > PE
-0.13248363235342275
Valuation > metrics > PB
1.8961792983836192
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-16.365649579363293
Profitability > metrics > ROA
-15.190720946155212
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.0918573297829258
Risk > metrics > Interest Coverage
-559.8277608915906
Risk > final Score
-2179
Risk > verdict
High
Liquidity > metrics > Current Ratio
126.56419694195911
Liquidity > metrics > Quick Ratio
126.56419694195911
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
80
Prev Valuations > 1
80
Prev Valuations > 2
80
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
0
Prev Risks > 0
25
Prev Risks > 1
32
Prev Risks > 2
-7815
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-13T00:51:25.384Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-13
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.1325
Earnings History > 0 > eps Estimate
-0.13
Earnings History > 0 > eps Difference
-0.0025
Earnings History > 0 > surprise Percent
-1.9231
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-14
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.11
Earnings History > 1 > eps Estimate
-0.08
Earnings History > 1 > eps Difference
-0.03
Earnings History > 1 > surprise Percent
-37.5
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-14
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.15
Earnings History > 2 > eps Estimate
-0.09
Earnings History > 2 > eps Difference
-0.06
Earnings History > 2 > surprise Percent
-66.6667
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-25
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.1749
Earnings History > 3 > eps Estimate
-0.0867
Earnings History > 3 > eps Difference
-0.0882
Earnings History > 3 > surprise Percent
-101.7301
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-14
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.65
Earnings History > 4 > eps Estimate
-0.48
Earnings History > 4 > eps Difference
-0.17
Earnings History > 4 > surprise Percent
-35.4167
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-14
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.66
Earnings History > 5 > eps Estimate
-0.67
Earnings History > 5 > eps Difference
0.01
Earnings History > 5 > surprise Percent
1.4925
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-15
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.73
Earnings History > 6 > eps Estimate
-0.79
Earnings History > 6 > eps Difference
0.06
Earnings History > 6 > surprise Percent
7.5949
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-27
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.64
Earnings History > 7 > eps Estimate
-0.85
Earnings History > 7 > eps Difference
0.21
Earnings History > 7 > surprise Percent
24.7059
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-14
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.86
Earnings History > 8 > eps Estimate
-1.12
Earnings History > 8 > eps Difference
0.26
Earnings History > 8 > surprise Percent
23.2143
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-14
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-1.11
Earnings History > 9 > eps Estimate
-0.92
Earnings History > 9 > eps Difference
-0.19
Earnings History > 9 > surprise Percent
-20.6522
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-15
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.16
Earnings History > 10 > eps Estimate
-0.14
Earnings History > 10 > eps Difference
-0.02
Earnings History > 10 > surprise Percent
-14.2857
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-31
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.18
Earnings History > 11 > eps Estimate
-0.19
Earnings History > 11 > eps Difference
0.01
Earnings History > 11 > surprise Percent
5.2632
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-14
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.18
Earnings History > 12 > eps Estimate
-0.18
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
0
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-12
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.18
Earnings History > 13 > eps Estimate
-0.19
Earnings History > 13 > eps Difference
0.01
Earnings History > 13 > surprise Percent
5.2632
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-16
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.18
Earnings History > 14 > eps Estimate
-0.17
Earnings History > 14 > eps Difference
-0.01
Earnings History > 14 > surprise Percent
-5.8824
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-31
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.2
Earnings History > 15 > eps Estimate
-0.17
Earnings History > 15 > eps Difference
-0.03
Earnings History > 15 > surprise Percent
-17.6471
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-15
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.18
Earnings History > 16 > eps Estimate
-0.14
Earnings History > 16 > eps Difference
-0.04
Earnings History > 16 > surprise Percent
-28.5714
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-16
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.22
Earnings History > 17 > eps Estimate
-0.38
Earnings History > 17 > eps Difference
0.16
Earnings History > 17 > surprise Percent
42.1053
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-17
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.26
Earnings History > 18 > eps Estimate
-
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-31
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.15
Earnings History > 19 > eps Estimate
-
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-12-04
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.08
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
-0.08
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-07-23
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.61
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
-0.61
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-06-30
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.0516
Earnings History > 22 > eps Estimate
0
Earnings History > 22 > eps Difference
-0.0516
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2019-12-31
Earnings History > 23 > report Date
2020-03-31
Earnings History > 23 > date
2019-12-31
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.0669
Earnings History > 23 > eps Estimate
0
Earnings History > 23 > eps Difference
-0.0669
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2019-09-30
Earnings History > 24 > report Date
2019-12-31
Earnings History > 24 > date
2019-09-30
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.0526
Earnings History > 24 > eps Estimate
0
Earnings History > 24 > eps Difference
-0.0526
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2019-06-30
Earnings History > 25 > report Date
2019-09-30
Earnings History > 25 > date
2019-06-30
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-0.1482
Earnings History > 25 > eps Estimate
0
Earnings History > 25 > eps Difference
-0.1482
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2019-03-31
Earnings History > 26 > report Date
2019-06-30
Earnings History > 26 > date
2019-03-31
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-0.2865
Earnings History > 26 > eps Estimate
0
Earnings History > 26 > eps Difference
-0.2865
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2018-12-31
Earnings History > 27 > report Date
2019-03-31
Earnings History > 27 > date
2018-12-31
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
-0.2122
Earnings History > 27 > eps Estimate
0
Earnings History > 27 > eps Difference
-0.2122
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2018-09-30
Earnings History > 28 > report Date
2018-10-16
Earnings History > 28 > date
2018-09-30
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
USD
Earnings History > 28 > eps Actual
-0.1
Earnings History > 28 > eps Estimate
0
Earnings History > 28 > eps Difference
-0.1
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2017-12-31
Earnings History > 29 > report Date
2018-03-31
Earnings History > 29 > date
2017-12-31
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
USD
Earnings History > 29 > eps Actual
-0.016
Earnings History > 29 > eps Estimate
0
Earnings History > 29 > eps Difference
-0.016
Earnings History > 29 > surprise Percent
-
Earnings History > 30 > period
2016-12-31
Earnings History > 30 > report Date
2017-03-31
Earnings History > 30 > date
2016-12-31
Earnings History > 30 > before After Market
-
Earnings History > 30 > currency
USD
Earnings History > 30 > eps Actual
-0.0238
Earnings History > 30 > eps Estimate
0
Earnings History > 30 > eps Difference
-0.0238
Earnings History > 30 > surprise Percent
-
Inhibikase Therapeutics, Inc. operates as a clinical-stage pharmaceutical company that develops therapeutics for Parkinson's disease and related disorders. Its lead product candidate is IkT-148009, a non-receptor Abelson tyrosine kinase inhibitor, which is in Phase 2a clinical trials to the treatment of Parkinson's disease and gastrointestinal tract. The company is also developing IkT-001Pro, a prodrug of the anticancer agent imatinib mesylate to treat stable phase chronic myelogenous leukemia. Inhibikase Therapeutics, Inc. has research and development collaborations with Johns Hopkins University, Arizona State University, and Michigan State University; and a collaborative research and development agreement with Sphaera Pharma Pte. Ltd. The company was founded in 2008 and is based in Atlanta, Georgia.
Stock Price
$ 0.00
0% increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AShowing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$8
Analyst Picks
Strong Buy
1
Buy
1
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Medium
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 80.76% of the total shares of Inhibikase Therapeutics Inc
1.
Sands Capital Ventures, LLC(14.6947%)
since
2025/06/30
2.
Soleus Capital Management, L.P.(8.488%)
since
2025/06/30
3.
Fairmount Funds Management LLC(8.2196%)
since
2025/06/30
4.
Perceptive Advisors LLC(7.29%)
since
2025/06/30
5.
COMMODORE CAPITAL LP(7.2433%)
since
2025/06/30
6.
ADAR1 Capital Management LLC(6.8738%)
since
2025/06/30
7.
Vanguard Group Inc(4.327%)
since
2025/06/30
8.
BlackRock Inc(3.6612%)
since
2025/06/30
9.
Blackstone Inc(3.5405%)
since
2025/06/30
10.
Vanguard Total Stock Mkt Idx Inv(2.9903%)
since
2025/07/31
11.
Nantahala Capital Management, LLC(2.9389%)
since
2025/06/30
12.
Geode Capital Management, LLC(1.4315%)
since
2025/06/30
13.
iShares Russell 2000 ETF(1.1088%)
since
2025/08/31
14.
Stonepine Capital Management Llc(0.9847%)
since
2025/06/30
15.
Fidelity Small Cap Index(0.8062%)
since
2025/06/30
16.
iShares Russell 2000 Value ETF(0.6433%)
since
2025/08/31
17.
State Street Corp(0.5339%)
since
2025/06/30
18.
Northern Trust Corp(0.527%)
since
2025/06/30
19.
Susquehanna International Group, LLP(0.5141%)
since
2025/06/30
20.
Vanguard Institutional Extnd Mkt Idx Tr(0.4605%)
since
2025/07/31
21.
Vanguard Russell 2000 ETF(0.3903%)
since
2025/07/31
22.
State St Russell Sm Cap® Indx SL Cl I(0.2841%)
since
2025/08/31
23.
Fidelity Extended Market Index(0.2452%)
since
2025/07/31
24.
Blair William & Co(0.2106%)
since
2025/06/30
25.
Charles Schwab Investment Management Inc(0.2044%)
since
2025/06/30
26.
Schwab Small Cap Index(0.2044%)
since
2025/07/31
27.
NT R2000 Index Fund - NL(0.1963%)
since
2025/06/30
28.
FMR Inc(0.1936%)
since
2025/06/30
29.
Fidelity Select Biotechnology(0.1905%)
since
2025/07/31
30.
iShares Micro-Cap ETF(0.1854%)
since
2025/08/31
31.
Bank of New York Mellon Corp(0.1778%)
since
2025/06/30
32.
NT R2000 Index Fund - DC - NL - 3(0.1565%)
since
2025/06/30
33.
Barclays PLC(0.148%)
since
2025/06/30
34.
iShares Russell 2000 Small-Cap Idx Instl(0.1406%)
since
2025/07/31
35.
Russell 2500™ Index Fund F(0.1088%)
since
2025/06/30
36.
Nuveen Small Cap Blend Idx R6(0.1056%)
since
2025/07/31
37.
Russell 2000 Index Non-Lendable Fund E(0.0893%)
since
2025/06/30
38.
Fidelity Series Total Market Index(0.0887%)
since
2025/07/31
39.
iShares Russell 2000 Growth ETF(0.0857%)
since
2025/08/31
40.
EQ/2000 Managed Volatility IB(0.0818%)
since
2025/07/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.1325
EPS Estimate
-0.13
EPS Difference
-0.0025
Surprise Percent
-1.9231%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.